GWPH

Gw Pharma ADR

$183.56 1.13 (0.61%)
10:49 EDT GWPH Stock Quote Delayed 15 Minutes
Dividend & Yield:       N/A (N/A)
P/E:       -
Market Cap:       5.18B
EPS:       -
Volume:       100,356
Day's Range:       183.02 - 187.69
52wk Range:       90.14 - 196.00
Previous Close:       119.03
Historical Data for GWPH
Date Open High Low Volume Close Change %
05/01/17 119.00 119.85 117.54 137,370 119.03 0.30   0.25%
04/28/17 118.69 119.49 118.24 116,341 118.73 0.30   0.25%
04/27/17 119.83 119.91 118.25 140,863 118.43 -0.83   -0.70%
04/26/17 116.52 120.00 116.50 299,810 119.26 2.52   2.16%
04/25/17 114.95 118.08 114.65 353,575 116.74 2.29   2.00%
04/24/17 115.55 116.02 114.00 338,805 114.45 -0.31   -0.27%
04/21/17 117.06 117.98 114.50 292,215 114.76 -1.06   -0.92%
04/20/17 116.69 118.22 115.60 199,372 115.82 -0.37   -0.32%
04/19/17 116.51 117.58 114.42 224,995 116.19 2.25   1.97%
04/18/17 116.06 116.17 113.61 280,889 113.94 -2.31   -1.99%
04/17/17 117.81 118.19 115.96 219,510 116.25 -0.82   -0.70%
04/13/17 118.22 118.50 116.78 170,347 117.07 -0.68   -0.58%
04/12/17 118.16 118.99 117.07 160,982 117.75 -0.50   -0.42%
04/11/17 118.00 120.37 118.00 253,045 118.25 0.32   0.27%
04/10/17 115.91 119.59 115.91 281,219 117.93 1.62   1.39%
04/07/17 116.26 117.33 115.05 218,394 116.31 0.33   0.28%
04/06/17 117.39 118.18 114.37 407,374 115.98 -1.11   -0.95%
04/05/17 119.08 119.83 116.43 269,163 117.09 -1.91   -1.61%
04/04/17 120.72 121.99 118.89 302,799 119.00 -1.81   -1.50%
04/03/17 121.25 121.80 119.99 240,271 120.81 -0.13   -0.11%
03/31/17 121.49 121.72 120.84 142,016 120.94 -0.41   -0.34%
03/30/17 121.75 121.84 120.48 128,944 121.35 -0.05   -0.04%
03/29/17 120.05 123.34 120.05 216,325 121.40 1.27   1.06%
03/28/17 121.42 122.78 120.01 222,321 120.13 -1.28   -1.05%
03/27/17 120.45 122.20 119.62 196,994 121.41 0.24   0.20%
03/24/17 121.50 123.33 120.58 168,930 121.17 0.05   0.04%
03/23/17 119.50 122.81 119.16 230,081 121.12 1.62   1.36%
03/22/17 118.71 120.31 118.00 191,576 119.50 0.44   0.37%
03/21/17 122.56 123.30 118.30 363,021 119.06 -3.41   -2.78%
03/20/17 123.57 123.57 122.07 202,950 122.47 -0.61   -0.50%
03/17/17 122.54 123.57 122.00 246,200 123.08 0.11   0.09%
03/16/17 124.51 124.75 122.61 168,900 122.97 -0.98   -0.79%
03/15/17 123.30 124.71 122.50 347,796 123.95 0.48   0.39%
03/14/17 123.15 124.36 122.11 270,718 123.47 0.14   0.11%
03/13/17 125.00 125.59 123.01 405,168 123.33 -1.74   -1.39%
03/10/17 126.00 126.99 122.79 494,551 125.07 -0.37   -0.29%
03/09/17 129.18 129.81 125.11 433,988 125.44 -4.15   -3.20%
03/08/17 127.75 130.89 127.75 366,347 129.59 2.19   1.72%
03/07/17 127.91 129.54 126.00 297,887 127.40 -1.59   -1.23%
03/06/17 130.97 131.04 128.26 384,735 128.99 -2.36   -1.80%
03/03/17 130.37 136.95 129.85 588,159 131.35 1.51   1.16%
03/02/17 128.29 131.39 127.88 602,726 129.84 1.53   1.19%
03/01/17 125.00 128.62 124.37 398,331 128.31 3.53   2.83%
02/28/17 125.04 126.42 124.25 139,532 124.78 -0.63   -0.50%
02/27/17 123.43 125.74 122.64 218,270 125.41 1.67   1.35%
02/24/17 122.98 124.00 120.39 348,791 123.74 -0.56   -0.45%
02/23/17 125.81 127.16 122.72 377,492 124.30 -0.87   -0.70%
02/22/17 128.89 129.21 123.84 461,967 125.17 -4.26   -3.29%
02/21/17 130.35 130.57 128.75 209,495 129.43 -0.16   -0.12%
02/17/17 0.00 129.59 129.59 0 129.59 -0.22   -0.17%
02/16/17 132.09 132.50 128.71 318,468 129.81 -2.70   -2.04%
02/15/17 132.49 133.30 130.06 512,122 132.51 0.10   0.08%
02/14/17 130.80 132.73 128.87 507,503 132.41 2.99   2.31%
02/13/17 128.30 131.33 127.65 358,503 129.42 1.19   0.93%
02/10/17 128.06 129.48 127.04 284,593 128.23 0.30   0.23%
02/09/17 129.87 130.83 126.75 453,143 127.93 -0.97   -0.75%
02/08/17 124.63 130.00 124.28 675,550 128.90 4.97   4.01%
02/07/17 119.97 125.02 118.19 687,059 123.93 3.17   2.63%
02/06/17 118.71 120.94 118.52 402,391 120.76 2.08   1.75%
02/03/17 115.80 118.84 115.06 330,721 118.68 3.38   2.93%

Navellier Ratings

Powered by Portfolio Grader

Total Grade

B
Buy

10 Stocks Set for Monster Growth

He found Apple at $4… Oracle at $6… Amazon at $40… Now legendary growth investor Louis Navellier is giving away his latest Research Report — for FREE!

Download your FREE COPY!